| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6199936 | Ophthalmology | 2014 | 8 Pages |
Abstract
Infliximab reduced the frequency of ocular attacks and improved visual acuity in patients with BD-related uveitis and was generally well tolerated with few serious adverse events.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Masaru MD, PhD, Takeshi MD, PhD, Sunao MD, PhD, Hiroshi MD, PhD, Kenichi MD, PhD, Toshikatsu MD, PhD, Kazuichi MD, PhD, Kei MD, PhD, Kuniaki MD, PhD, Etsuko MD, PhD, Keiko MD, Junko MD, PhD, Nobuyuki MD, PhD, Koh-hei MD, PhD, Nobuhisa MD, PhD,